Vortioxetine
Generic name: Pronounced as (vor'' tye ox' e teen)
Medical Content Reviewed By HelloPharmacist Staff
Last Revised - 01/15/2022
On this page
- Why is this medication prescribed?
- How should this medicine be used?
- Other uses for this medicine
- What special precautions should I follow?
- What special dietary instructions should I follow?
- What should I do if I forget a dose?
- What side effects can this medication cause?
- What should I know about STORAGE and DISPOSAL of this medication?
- What should I do in case of OVERDOSE?
- What OTHER INFORMATION should I know?
- Drug interactions
IMPORTANT WARNING
A small number of children, teenagers, and young adults (up to 24 years of age) who took antidepressants ('mood elevators') such as vortioxetine during clinical studies became suicidal (thinking about harming or killing oneself or planning or trying to do so). Children, teenagers, and young adults who take antidepressants to treat depression or other mental illnesses may be more likely to become suicidal than children, teenagers, and young adults who do not take antidepressants to treat these conditions. However, there are also risks when depression is not treated in children and teenagers. Talk to your child's doctor about these risks and whether your child should take an antidepressant. Vortioxetine has not been studied in children younger than 18 years of age.
You should know that your mental health may change in unexpected ways when you take vortioxetine or other antidepressants even if you are an adult over 24 years of age. You may become suicidal, especially at the beginning of your treatment and any time that your dose is increased or decreased. You, your family, or your caregiver should call your doctor right away if you experience any of the following symptoms: new or worsening depression; thinking about harming or killing yourself, or planning or trying to do so; extreme worry; agitation; panic attacks; difficulty falling asleep or staying asleep; aggressive behavior; irritability; acting without thinking; severe restlessness; and frenzied abnormal excitement. Be sure that your family or caregiver knows which symptoms may be serious so they can call the doctor if you are unable to seek treatment on your own.
Your healthcare provider will want to see you often while you are taking vortioxetine, especially at the beginning of your treatment. Be sure to keep all appointments for office visits with your doctor.
The doctor or pharmacist will give you the manufacturer's patient information sheet (Medication Guide) when you begin treatment with vortioxetine. Read the information carefully and ask your doctor or pharmacist if you have any questions. You can also obtain the Medication Guide from the FDA website: http://www.fda.gov/Drugs/DrugSafety/ucm085729.htm.
No matter what your age, before you take an antidepressant, you, your parent, or your caregiver should talk to your doctor about the risks and benefits of treating your condition with an antidepressant or with other treatments. You should also talk about the risks and benefits of not treating your condition. You should know that having depression or another mental illness greatly increases the risk that you will become suicidal. This risk is higher if you or anyone in your family has or has ever had bipolar disorder (mood that changes from depressed to abnormally excited) or mania (frenzied, abnormally excited mood) or has thought about or attempted suicide. Talk to your doctor about your condition, symptoms, and personal and family medical history. You and your doctor will decide what type of treatment is right for you.
Why is this medication prescribed?
Vortioxetine is used to treat depression in adults. Vortioxetine is in a class of medications called serotonin modulators. It works mainly by increasing the amount of serotonin, a natural substance in the brain that helps maintain mental balance.
How should this medicine be used?
Vortioxetine comes as a tablet to take by mouth. It is usually taken with or without food once a day. Take vortioxetine at around the same time every day. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take vortioxetine exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.
Your doctor may adjust your dose of vortioxetine depending on how well you respond to treatment and whether you experience side effects. Be sure to talk to your doctor about how you are feeling during your treatment with vortioxetine.
It may take 2 to 4 weeks or longer before you feel the full benefit of vortioxetine. Continue to take vortioxetine even if you feel well. Do not stop taking vortioxetine without talking to your doctor. Your doctor will probably decrease your dose gradually. If you suddenly stop taking vortioxetine, you may experience withdrawal symptoms such as headache, mood changes, irritability, agitation, nausea, dizziness, burning, numbness, or tingling in the hands or feet, anxiety, confusion, sweating, shaking, frenzied or abnormally excited mood, ringing in the ears, tiredness, difficulty falling asleep or staying asleep. and seizures. Tell your doctor if you experience any of these symptoms while you are decreasing your dose of vortioxetine or soon after you stop taking vortioxetine.
Other uses for this medicine
This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.
What special precautions should I follow?
Before taking vortioxetine,
-
tell your doctor and pharmacist if you are allergic to vortioxetine, any other medications, or any of the ingredients in vortioxetine tablets. Ask your pharmacist or check the Medication Guide for a list of the ingredients.
-
tell your doctor if you are taking monoamine oxidase (MAO) inhibitors, including isocarboxazid (Marplan), linezolid (Zyvox), methylene blue, phenelzine (Nardil), selegiline (Emsam, Zelapar), and tranylcypromine (Parnate) or if you have stopped taking them within the past 2 weeks. Your doctor may tell you not to take vortioxetine. If you stop taking vortioxetine, you should wait at least 21 days before you start to take an MAO inhibitor.
-
tell your doctor and pharmacist what other prescription and nonprescription medications, and vitamins, nutritional supplements you are taking or plan to take. Be sure to mention any of the following: amphetamines such as amphetamine (in Adderall, in Mydayis), dextroamphetamine (Dexedrine, in Adderall), and methamphetamine (Desoxyn); anticoagulants ('blood thinners') such as warfarin (Coumadin, Jantoven); antidepressants ('mood elevators') such as amitriptyline, amoxapine, clomipramine (Anafranil), desipramine (Norpramin), doxepin (Silenor), imipramine (Tofranil), nortriptyline (Pamelor), protriptyline, and trimipramine; bupropion (Aplenzin, Contrave, Forfivo, Wellbutrin, Zyban); aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen (Advil, Motrin) and naproxen (Aleve, Naprosyn); buspirone; carbamazepine (Carbatrol, Equetro, Tegretol, others); clopidogrel (Plavix); diuretics ('water pills'); fentanyl (Actiq, Duragesic, Fentora, Subsys); heparin; lithium (Lithobid); medications for mental illness; medications for migraine headaches such as almotriptan, eletriptan (Relpax), frovatriptan (Frova), naratriptan (Amerge), rizatriptan (Maxalt), sumatriptan (Imitrex), and zolmitriptan (Zomig); phenytoin (Dilantin, Phenytek); quinidine (in Nuedexta); rifampin (Rifadin, Rimactane); other selective serotonin-reuptake inhibitors such as citalopram (Celexa), escitalopram (Lexapro), fluoxetine (Prozac, in Symbyax), fluvoxamine (Luvox), paroxetine (Brisdelle, Paxil, Pexeva), and sertraline (Zoloft); serotonin and norepinephrine reuptake inhibitors such as duloxetine (Cymbalta), desvenlafaxine (Pristiq), and venlafaxine (Effexor); and tramadol (Conzip, Qdola, Ulltram, in Ultracet). Your doctor may need to change the doses of your medications or monitor you carefully for side effects.
-
tell your doctor what herbal products and nutritional supplements you are taking, especially St. John's wort and tryptophan.
-
tell your doctor if you have a low level of sodium in your blood, if you drink or have ever drunk large amounts of alcohol, and if you have or have ever had seizures, glaucoma (increased pressure in the eye that may cause loss of sight), or bleeding problems.
-
tell your doctor if you are pregnant, plan to become pregnant, or are breastfeeding. If you become pregnant while taking vortioxetine, call your doctor. Vortioxetine may cause problems in newborns following delivery if it is taken during the last few months of pregnancy.
-
if you are having surgery, including dental surgery, or a medical test that involves dyes, tell the doctor or dentist that you are taking vortioxetine.
-
you should know that vortioxetine may affect your judgment, thinking, and movements. Do not drive a car or operate machinery until you know how this medication affects you.
-
ask your doctor about the safe use of alcoholic beverages while you are taking vortioxetine.
-
you should know that vortioxetine may cause angle-closure glaucoma (a condition where the fluid is suddenly blocked and unable to flow out of the eye causing a quick, severe increase in eye pressure which may lead to a loss of vision). Talk to your doctor about having an eye examination before you start taking this medication. If you have nausea, eye pain, changes in vision, such as seeing colored rings around lights, and swelling or redness in or around the eye, call your doctor or get emergency medical treatment right away.
What special dietary instructions should I follow?
Unless your doctor tells you otherwise, continue your normal diet.
What should I do if I forget a dose?
Take the missed dose as soon as you remember it. However, if it is almost time for the next dose, skip the missed dose and continue your regular dosing schedule. Do not take a double dose to make up for a missed one.
What side effects can this medication cause?
-
Vortioxetine may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:
-
nausea
-
vomiting
-
diarrhea
-
constipation
-
gas
-
dry mouth
-
dizziness
-
unusual dreams
-
sexual problems in males; decreased sex drive, inability to get or keep an erection, or delayed or absent ejaculation
-
sexual problems in females; decreased sex drive, or delayed orgasm or unable to have an orgasm
-
-
Some side effects can be serious. If you experience any of these symptoms or those listed in the IMPORTANT WARNING or SPECIAL PRECAUTIONS sections, call your doctor immediately:
-
rash
-
hives
-
itching
-
swelling of the eyes, face, lips, tongue, or throat
-
hoarseness
-
difficulty breathing or swallowing
-
unusual bruising or bleeding
-
fever, sweating, confusion, fast or irregular heartbeat, severe muscle stiffness or twitching, agitation, hallucinations, loss of coordination, nausea, vomiting, or diarrhea
-
nosebleed
-
headache
-
difficulty concentrating
-
memory problems
-
confusion
-
weakness
-
unsteadiness
-
hallucinations
-
fainting
-
seizures
-
coma (loss of consciousness for a period of time)
-
-
Vortioxetine may cause other side effects. Call your doctor if you have any unusual problems while taking this medication.
-
If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online (http://www.fda.gov/Safety/MedWatch) or by phone (1-800-332-1088).
What should I know about STORAGE and DISPOSAL of this medication?
Keep this medication in the container it came in, tightly closed, and out of reach of children. Store it at room temperature and away from excess heat and moisture (not in the bathroom).
Unneeded medications should be disposed of in special ways to ensure that pets, children, and other people cannot consume them. However, you should not flush this medication down the toilet. Instead, the best way to dispose of your medication is through a medicine take-back program. Talk to your pharmacist or contact your local garbage/recycling department to learn about take-back programs in your community. See the FDA's Safe Disposal of Medicines website (http://goo.gl/c4Rm4p) for more information if you do not have access to a take-back program.
It is important to keep all medication out of sight and reach of children as many containers (such as weekly pill minders and those for eye drops, creams, patches, and inhalers) are not child-resistant and young children can open them easily. To protect young children from poisoning, always lock safety caps and immediately place the medication in a safe location – one that is up and away and out of their sight and reach. http://www.upandaway.org
What should I do in case of OVERDOSE?
In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at https://www.poisonhelp.org/help. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911.
Symptoms of overdose may include the following:
-
nausea
-
dizziness
-
diarrhea
-
stomach pain
-
itching
-
sleepiness
-
flushing
-
agitation, hallucinations, fever, sweating, confusion, fast heartbeat, shivering, severe muscle stiffness or twitching, loss of coordination, nausea, vomiting, or diarrhea
-
seizures
What OTHER INFORMATION should I know?
Keep all appointments with your doctor.
Before having any laboratory test (especially those that involve methylene blue), tell your doctor and the laboratory personnel that you are taking vortioxetine.
Do not let anyone else take your medication. Ask your pharmacist any questions you have about refilling your prescription.
It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.
Drug interactions
Drug | Interaction |
---|---|
Repaglinide | Repaglinide The metabolism of Vortioxetine can be decreased when combined with Repaglinide. |
Montelukast | Montelukast The metabolism of Vortioxetine can be decreased when combined with Montelukast. |
Leflunomide | Leflunomide The metabolism of Vortioxetine can be decreased when combined with Leflunomide. |
Delavirdine | Delavirdine The metabolism of Vortioxetine can be decreased when combined with Delavirdine. |
Nevirapine | Nevirapine The metabolism of Vortioxetine can be increased when combined with Nevirapine. |
Atorvastatin | Atorvastatin The metabolism of Vortioxetine can be decreased when combined with Atorvastatin. |
Dolasetron | Dolasetron The risk or severity of adverse effects can be increased when Dolasetron is combined with Vortioxetine. |
Candesartan | Candesartan The metabolism of Vortioxetine can be decreased when combined with Candesartan. |
Cilostazol | Cilostazol Cilostazol may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Clopidogrel | Clopidogrel The metabolism of Vortioxetine can be decreased when combined with Clopidogrel. |
Diphenoxylate | Diphenoxylate The risk or severity of adverse effects can be increased when Diphenoxylate is combined with Vortioxetine. |
Erythromycin and Sulfisoxazole | Erythromycin and Sulfisoxazole The metabolism of Vortioxetine can be decreased when combined with Erythromycin. |
Estrogen and Progestin (Oral Contraceptives) | Estrogen and Progestin (Oral Contraceptives) Conjugated estrogens may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Fenofibrate | Fenofibrate The metabolism of Vortioxetine can be decreased when combined with Fenofibrate. |
Guanfacine | Guanfacine The risk or severity of adverse effects can be increased when Guanfacine is combined with Vortioxetine. |
Magnesium Hydroxide | Magnesium Hydroxide Vortioxetine may decrease the excretion rate of Magnesium hydroxide which could result in a higher serum level. |
Methylergonovine | Methylergonovine Methylergometrine may increase the vasoconstricting activities of Vortioxetine. |
Mycophenolate | Mycophenolate Mycophenolic acid may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Naratriptan | Naratriptan The risk or severity of adverse effects can be increased when Naratriptan is combined with Vortioxetine. |
Olsalazine | Olsalazine Olsalazine may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Paregoric | Paregoric The metabolism of Vortioxetine can be decreased when combined with Morphine. |
Penbutolol | Penbutolol The metabolism of Vortioxetine can be decreased when combined with Acebutolol. |
Pentazocine | Pentazocine The risk or severity of adverse effects can be increased when Pentazocine is combined with Vortioxetine. |
Potassium | Potassium Potassium cation may increase the excretion rate of Vortioxetine which could result in a lower serum level and potentially a reduction in efficacy. |
Prednisone | Prednisone The metabolism of Vortioxetine can be increased when combined with Prednisone. |
Ranitidine | Ranitidine The metabolism of Vortioxetine can be decreased when combined with Ranitidine. |
Reserpine | Reserpine The risk or severity of adverse effects can be increased when Reserpine is combined with Vortioxetine. |
Rizatriptan | Rizatriptan The risk or severity of adverse effects can be increased when Rizatriptan is combined with Vortioxetine. |
Sumatriptan | Sumatriptan The risk or severity of adverse effects can be increased when Sumatriptan is combined with Vortioxetine. |
Tacrolimus | Tacrolimus The metabolism of Tacrolimus can be decreased when combined with Vortioxetine. |
Tizanidine | Tizanidine The risk or severity of adverse effects can be increased when Tizanidine is combined with Vortioxetine. |
Triamcinolone | Triamcinolone The metabolism of Vortioxetine can be increased when combined with Triamcinolone. |
Zolmitriptan | Zolmitriptan The risk or severity of vasospastic reactions can be increased when Zolmitriptan is combined with Vortioxetine. |
Ampicillin Injection | Ampicillin Injection Ampicillin may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Doxycycline Injection | Doxycycline Injection Doxycycline may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Fluconazole Injection | Fluconazole Injection The metabolism of Vortioxetine can be decreased when combined with Fluconazole. |
Foscarnet Injection | Foscarnet Injection Foscarnet may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Hydromorphone Injection | Hydromorphone Injection The risk or severity of adverse effects can be increased when Hydromorphone is combined with Vortioxetine. |
Levofloxacin Injection | Levofloxacin Injection Levofloxacin may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Meperidine Injection | Meperidine Injection The risk or severity of adverse effects can be increased when Meperidine is combined with Vortioxetine. |
Metoclopramide Injection | Metoclopramide Injection The risk or severity of sedation can be increased when Metoclopramide is combined with Vortioxetine. |
Metronidazole Injection | Metronidazole Injection The metabolism of Vortioxetine can be decreased when combined with Metronidazole. |
Morphine Injection | Morphine Injection The metabolism of Vortioxetine can be decreased when combined with Morphine. |
Pamidronate Injection | Pamidronate Injection Pamidronic acid may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Vancomycin Injection | Vancomycin Injection Vortioxetine may decrease the excretion rate of Vancomycin which could result in a higher serum level. |
Zidovudine Injection | Zidovudine Injection The metabolism of Vortioxetine can be decreased when combined with Zidovudine. |
Altretamine | Altretamine The metabolism of Vortioxetine can be decreased when combined with Amphetamine. |
Cefuroxime | Cefuroxime Cefuroxime may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Cyclosporine | Cyclosporine The metabolism of Cyclosporine can be decreased when combined with Vortioxetine. |
Ondansetron | Ondansetron The risk or severity of adverse effects can be increased when Ondansetron is combined with Vortioxetine. |
Granisetron | Granisetron The risk or severity of adverse effects can be increased when Granisetron is combined with Vortioxetine. |
Torsemide | Torsemide The metabolism of Vortioxetine can be decreased when combined with Torasemide. |
Olanzapine | Olanzapine The risk or severity of adverse effects can be increased when Olanzapine is combined with Vortioxetine. |
Alosetron | Alosetron The risk or severity of adverse effects can be increased when Alosetron is combined with Vortioxetine. |
Entacapone | Entacapone The risk or severity of adverse effects can be increased when Entacapone is combined with Vortioxetine. |
Eprosartan | Eprosartan Vortioxetine may decrease the antihypertensive activities of Eprosartan. |
Hydroxychloroquine | Hydroxychloroquine The metabolism of Vortioxetine can be decreased when combined with Hydroxychloroquine. |
Meloxicam | Meloxicam Meloxicam may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Oxcarbazepine | Oxcarbazepine The metabolism of Vortioxetine can be increased when combined with Oxcarbazepine. |
Pantoprazole | Pantoprazole The metabolism of Vortioxetine can be decreased when combined with Pantoprazole. |
Telmisartan | Telmisartan The metabolism of Vortioxetine can be decreased when combined with Telmisartan. |
Temozolomide | Temozolomide Temozolomide may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Zaleplon | Zaleplon Zaleplon may increase the central nervous system depressant (CNS depressant) activities of Vortioxetine. |
Anakinra | Anakinra The metabolism of Vortioxetine can be increased when combined with Anakinra. |
Desloratadine | Desloratadine The risk or severity of adverse effects can be increased when Desloratadine is combined with Vortioxetine. |
Linezolid | Linezolid The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Vortioxetine. |
Trimipramine | Trimipramine The metabolism of Vortioxetine can be decreased when combined with Trimipramine. |
Etanercept Injection | Etanercept Injection The metabolism of Vortioxetine can be increased when combined with Etanercept. |
Glycopyrrolate | Glycopyrrolate Vortioxetine may increase the central nervous system depressant (CNS depressant) activities of Glycopyrronium. |
Modafinil | Modafinil The metabolism of Vortioxetine can be decreased when combined with Modafinil. |
Perindopril | Perindopril Perindopril may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Tenofovir | Tenofovir Tenofovir may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Choline Magnesium Trisalicylate | Choline Magnesium Trisalicylate Choline magnesium trisalicylate may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Sirolimus | Sirolimus The metabolism of Sirolimus can be decreased when combined with Vortioxetine. |
Dutasteride | Dutasteride The metabolism of Vortioxetine can be decreased when combined with Dutasteride. |
Epinephrine Injection | Epinephrine Injection The metabolism of Vortioxetine can be decreased when combined with Epinephrine. |
Eplerenone | Eplerenone Eplerenone may increase the excretion rate of Vortioxetine which could result in a lower serum level and potentially a reduction in efficacy. |
Escitalopram | Escitalopram The risk or severity of serotonin syndrome can be increased when Escitalopram is combined with Vortioxetine. |
Olmesartan | Olmesartan Vortioxetine may decrease the antihypertensive activities of Olmesartan. |
Zonisamide | Zonisamide The metabolism of Vortioxetine can be decreased when combined with Zonisamide. |
Adalimumab Injection | Adalimumab Injection The metabolism of Vortioxetine can be increased when combined with Adalimumab. |
Aripiprazole | Aripiprazole The risk or severity of adverse effects can be increased when Aripiprazole is combined with Vortioxetine. |
Atomoxetine | Atomoxetine The risk or severity of adverse effects can be increased when Atomoxetine is combined with Vortioxetine. |
Dexmethylphenidate | Dexmethylphenidate The risk or severity of adverse effects can be increased when Dexmethylphenidate is combined with Vortioxetine. |
Atazanavir | Atazanavir Atazanavir may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Almotriptan | Almotriptan The metabolism of Vortioxetine can be decreased when combined with Almotriptan. |
Eletriptan | Eletriptan The metabolism of Vortioxetine can be increased when combined with Eletriptan. |
Mefloquine | Mefloquine The metabolism of Vortioxetine can be decreased when combined with Mefloquine. |
Rosuvastatin | Rosuvastatin The metabolism of Vortioxetine can be decreased when combined with Rosuvastatin. |
Vardenafil | Vardenafil The metabolism of Vortioxetine can be decreased when combined with Vardenafil. |
Aprepitant | Aprepitant The metabolism of Vortioxetine can be decreased when combined with Aprepitant. |
Emtricitabine | Emtricitabine Emtricitabine may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Memantine | Memantine The metabolism of Vortioxetine can be decreased when combined with Memantine. |
Tegaserod | Tegaserod The metabolism of Vortioxetine can be decreased when combined with Tegaserod. |
Tadalafil | Tadalafil Tadalafil may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Frovatriptan | Frovatriptan The risk or severity of adverse effects can be increased when Frovatriptan is combined with Vortioxetine. |
Progesterone | Progesterone The metabolism of Vortioxetine can be decreased when combined with Progesterone. |
Apomorphine Injection | Apomorphine Injection The risk or severity of hypotension can be increased when Apomorphine is combined with Vortioxetine. |
Infliximab Injection | Infliximab Injection The metabolism of Vortioxetine can be increased when combined with Infliximab. |
Oxandrolone | Oxandrolone The metabolism of Vortioxetine can be decreased when combined with Oxandrolone. |
Protriptyline | Protriptyline The risk or severity of adverse effects can be increased when Protriptyline is combined with Vortioxetine. |
Rifaximin | Rifaximin The metabolism of Vortioxetine can be increased when combined with Rifaximin. |
Duloxetine | Duloxetine The metabolism of Vortioxetine can be decreased when combined with Duloxetine. |
Norethindrone | Norethindrone The metabolism of Vortioxetine can be decreased when combined with Norethisterone. |
Tinidazole | Tinidazole Tinidazole may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Trospium | Trospium Vortioxetine may increase the central nervous system depressant (CNS depressant) activities of Trospium. |
Bosentan | Bosentan The metabolism of Vortioxetine can be increased when combined with Bosentan. |
Cefditoren | Cefditoren Cefdinir may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Cinacalcet | Cinacalcet The metabolism of Vortioxetine can be decreased when combined with Cinacalcet. |
Cyanocobalamin Injection | Cyanocobalamin Injection Hydroxocobalamin may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Erlotinib | Erlotinib The metabolism of Vortioxetine can be decreased when combined with Erlotinib. |
Eszopiclone | Eszopiclone The risk or severity of CNS depression can be increased when Vortioxetine is combined with Eszopiclone. |
Ganciclovir | Ganciclovir Ganciclovir may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Ribavirin | Ribavirin Ribavirin may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Solifenacin | Solifenacin Vortioxetine may increase the central nervous system depressant (CNS depressant) activities of Solifenacin. |
Valganciclovir | Valganciclovir Valganciclovir may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Voriconazole | Voriconazole The metabolism of Vortioxetine can be decreased when combined with Voriconazole. |
Adefovir | Adefovir Adefovir may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Dextroamphetamine | Dextroamphetamine The metabolism of Vortioxetine can be decreased when combined with Amphetamine. |
Peginterferon Alfa-2b (PEG-Intron) | Peginterferon Alfa-2b (PEG-Intron) The metabolism of Vortioxetine can be increased when combined with Peginterferon alfa-2b. |
Sodium Oxybate | Sodium Oxybate Sodium oxybate may increase the central nervous system depressant (CNS depressant) activities of Vortioxetine. |
Isocarboxazid | Isocarboxazid The metabolism of Vortioxetine can be decreased when combined with Isocarboxazid. |
Ramelteon | Ramelteon The risk or severity of adverse effects can be increased when Ramelteon is combined with Vortioxetine. |
Darifenacin | Darifenacin The metabolism of Darifenacin can be decreased when combined with Vortioxetine. |
Fentanyl | Fentanyl The risk or severity of adverse effects can be increased when Fentanyl is combined with Vortioxetine. |
Pregabalin | Pregabalin The therapeutic efficacy of Vortioxetine can be increased when used in combination with Pregabalin. |
Deferasirox | Deferasirox The metabolism of Vortioxetine can be decreased when combined with Deferasirox. |
Phenylephrine | Phenylephrine The risk or severity of hypertension can be increased when Phenylephrine is combined with Vortioxetine. |
Tipranavir | Tipranavir The metabolism of Tipranavir can be decreased when combined with Vortioxetine. |
Felbamate | Felbamate The metabolism of Vortioxetine can be decreased when combined with Felbamate. |
Ranolazine | Ranolazine The serum concentration of Vortioxetine can be increased when it is combined with Ranolazine. |
Abatacept Injection | Abatacept Injection The metabolism of Vortioxetine can be increased when combined with Abatacept. |
Rasagiline | Rasagiline The metabolism of Vortioxetine can be decreased when combined with Rasagiline. |
Imatinib | Imatinib The metabolism of Vortioxetine can be decreased when combined with Imatinib. |
Sitagliptin | Sitagliptin The metabolism of Vortioxetine can be decreased when combined with Sitagliptin. |
Varenicline | Varenicline Varenicline may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Gefitinib | Gefitinib The metabolism of Vortioxetine can be decreased when combined with Gefitinib. |
Albuterol | Albuterol Salbutamol may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Paliperidone | Paliperidone The risk or severity of adverse effects can be increased when Paliperidone is combined with Vortioxetine. |
Bortezomib | Bortezomib The metabolism of Vortioxetine can be decreased when combined with Bortezomib. |
Clofarabine Injection | Clofarabine Injection Clofarabine may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Lubiprostone | Lubiprostone Lubiprostone may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Primaquine | Primaquine The metabolism of Vortioxetine can be decreased when combined with Primaquine. |
Aliskiren | Aliskiren Vortioxetine may decrease the antihypertensive activities of Aliskiren. |
Pemetrexed Injection | Pemetrexed Injection Vortioxetine may decrease the excretion rate of Pemetrexed which could result in a higher serum level. |
Dimenhydrinate | Dimenhydrinate The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Vortioxetine. |
Lisdexamfetamine | Lisdexamfetamine The risk or severity of serotonin syndrome can be increased when Lisdexamfetamine is combined with Vortioxetine. |
Nabilone | Nabilone Nabilone may increase the central nervous system depressant (CNS depressant) activities of Vortioxetine. |
Sorafenib | Sorafenib The metabolism of Vortioxetine can be decreased when combined with Sorafenib. |
Sunitinib | Sunitinib The risk or severity of QTc prolongation and torsade de pointes can be increased when Sunitinib is combined with Vortioxetine. |
Dronabinol | Dronabinol Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Vortioxetine. |
Lapatinib | Lapatinib The metabolism of Vortioxetine can be decreased when combined with Lapatinib. |
Levocetirizine | Levocetirizine The risk or severity of adverse effects can be increased when Levocetirizine is combined with Vortioxetine. |
Pegaptanib Injection | Pegaptanib Injection Pegaptanib may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Dasatinib | Dasatinib The metabolism of Vortioxetine can be decreased when combined with Dasatinib. |
Mexiletine | Mexiletine The metabolism of Vortioxetine can be decreased when combined with Mexiletine. |
Armodafinil | Armodafinil The metabolism of Vortioxetine can be decreased when combined with Armodafinil. |
Azacitidine Injection | Azacitidine Injection Azacitidine may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Temsirolimus | Temsirolimus The metabolism of Temsirolimus can be decreased when combined with Vortioxetine. |
Lenalidomide | Lenalidomide Lenalidomide may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Nilotinib | Nilotinib The metabolism of Vortioxetine can be decreased when combined with Nilotinib. |
Bexarotene | Bexarotene The metabolism of Vortioxetine can be decreased when combined with Bexarotene. |
Budesonide | Budesonide The metabolism of Vortioxetine can be increased when combined with Budesonide. |
Chloramphenicol Injection | Chloramphenicol Injection The metabolism of Vortioxetine can be decreased when combined with Chloramphenicol. |
Desmopressin | Desmopressin Desmopressin may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
OnabotulinumtoxinA Injection | OnabotulinumtoxinA Injection The risk or severity of adverse effects can be increased when Botulinum toxin type A is combined with Vortioxetine. |
RimabotulinumtoxinB Injection | RimabotulinumtoxinB Injection The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Vortioxetine. |
Doripenem Injection | Doripenem Injection Doripenem may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Etravirine | Etravirine The metabolism of Vortioxetine can be decreased when combined with Etravirine. |
Arsenic Trioxide Injection | Arsenic Trioxide Injection Arsenic trioxide may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Desvenlafaxine | Desvenlafaxine The risk or severity of adverse effects can be increased when Desvenlafaxine is combined with Vortioxetine. |
Cevimeline | Cevimeline Cevimeline may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Nebivolol | Nebivolol The metabolism of Nebivolol can be decreased when combined with Vortioxetine. |
Tretinoin | Tretinoin The metabolism of Vortioxetine can be decreased when combined with Tretinoin. |
Pilocarpine | Pilocarpine The metabolism of Vortioxetine can be decreased when combined with Pilocarpine. |
Flecainide | Flecainide The metabolism of Flecainide can be decreased when combined with Vortioxetine. |
Certolizumab Injection | Certolizumab Injection The metabolism of Vortioxetine can be increased when combined with Certolizumab pegol. |
Irinotecan Injection | Irinotecan Injection The metabolism of Vortioxetine can be decreased when combined with Irinotecan. |
Daptomycin Injection | Daptomycin Injection Daptomycin may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Praziquantel | Praziquantel The metabolism of Vortioxetine can be decreased when combined with Praziquantel. |
Mitotane | Mitotane The metabolism of Vortioxetine can be increased when combined with Mitotane. |
Methylnaltrexone Injection | Methylnaltrexone Injection Methylnaltrexone may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Rufinamide | Rufinamide The risk or severity of adverse effects can be increased when Rufinamide is combined with Vortioxetine. |
Midazolam | Midazolam The risk or severity of adverse effects can be increased when Midazolam is combined with Vortioxetine. |
Naltrexone Injection | Naltrexone Injection The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Vortioxetine. |
Dexrazoxane Injection | Dexrazoxane Injection Dexrazoxane may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Eltrombopag | Eltrombopag The metabolism of Vortioxetine can be decreased when combined with Eltrombopag. |
Milnacipran | Milnacipran The risk or severity of adverse effects can be increased when Milnacipran is combined with Vortioxetine. |
Dexlansoprazole | Dexlansoprazole The metabolism of Vortioxetine can be decreased when combined with Dexlansoprazole. |
Plerixafor Injection | Plerixafor Injection Plerixafor may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Fesoterodine | Fesoterodine Fesoterodine may increase the central nervous system depressant (CNS depressant) activities of Vortioxetine. |
Betaxolol | Betaxolol The metabolism of Vortioxetine can be decreased when combined with Betaxolol. |
Iloperidone | Iloperidone The risk or severity of adverse effects can be increased when Iloperidone is combined with Vortioxetine. |
Prasugrel | Prasugrel The metabolism of Vortioxetine can be decreased when combined with Prasugrel. |
Lacosamide | Lacosamide The metabolism of Vortioxetine can be decreased when combined with Lacosamide. |
Everolimus | Everolimus The metabolism of Vortioxetine can be decreased when combined with Everolimus. |
Tolvaptan (low blood sodium) | Tolvaptan (low blood sodium) Tolvaptan may increase the excretion rate of Vortioxetine which could result in a lower serum level and potentially a reduction in efficacy. |
Dronedarone | Dronedarone The metabolism of Dronedarone can be decreased when combined with Vortioxetine. |
AbobotulinumtoxinA Injection | AbobotulinumtoxinA Injection The risk or severity of adverse effects can be increased when Botulinum toxin type A is combined with Vortioxetine. |
Pralatrexate Injection | Pralatrexate Injection Pralatrexate may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Palonosetron Injection | Palonosetron Injection The risk or severity of adverse effects can be increased when Palonosetron is combined with Vortioxetine. |
Saxagliptin | Saxagliptin Saxagliptin may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Telavancin Injection | Telavancin Injection Telavancin may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Romidepsin Injection | Romidepsin Injection The metabolism of Vortioxetine can be decreased when combined with Romidepsin. |
Tapentadol | Tapentadol Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Vortioxetine. |
Topotecan | Topotecan Topotecan may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Golimumab Injection | Golimumab Injection The metabolism of Vortioxetine can be increased when combined with Golimumab. |
Pazopanib | Pazopanib The metabolism of Vortioxetine can be decreased when combined with Pazopanib. |
Asenapine | Asenapine The risk or severity of adverse effects can be increased when Asenapine is combined with Vortioxetine. |
Vigabatrin | Vigabatrin The risk or severity of adverse effects can be increased when Vigabatrin is combined with Vortioxetine. |
Pitavastatin | Pitavastatin The metabolism of Vortioxetine can be decreased when combined with Pitavastatin. |
Albendazole | Albendazole The metabolism of Vortioxetine can be decreased when combined with Albendazole. |
Levonorgestrel | Levonorgestrel The metabolism of Vortioxetine can be decreased when combined with Levonorgestrel. |
Oxymorphone | Oxymorphone The risk or severity of adverse effects can be increased when Oxymorphone is combined with Vortioxetine. |
Tocilizumab Injection | Tocilizumab Injection The metabolism of Vortioxetine can be increased when combined with Tocilizumab. |
Dalfampridine | Dalfampridine Dalfampridine may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
IncobotulinumtoxinA Injection | IncobotulinumtoxinA Injection The risk or severity of adverse effects can be increased when Botulinum toxin type A is combined with Vortioxetine. |
Cabazitaxel Injection | Cabazitaxel Injection The metabolism of Vortioxetine can be decreased when combined with Cabazitaxel. |
Ceftaroline Injection | Ceftaroline Injection Ceftaroline fosamil may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Lurasidone | Lurasidone The risk or severity of adverse effects can be increased when Lurasidone is combined with Vortioxetine. |
Acetaminophen Injection | Acetaminophen Injection The metabolism of Vortioxetine can be decreased when combined with Acetaminophen. |
Vilazodone | Vilazodone The metabolism of Vortioxetine can be decreased when combined with Vilazodone. |
Ipilimumab Injection | Ipilimumab Injection Ipilimumab may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Denileukin Diftitox Injection | Denileukin Diftitox Injection Aldesleukin may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Terbutaline Injection | Terbutaline Injection Terbutaline may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Roflumilast | Roflumilast Roflumilast may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Rilpivirine | Rilpivirine The metabolism of Vortioxetine can be decreased when combined with Rilpivirine. |
Cyclophosphamide Injection | Cyclophosphamide Injection The metabolism of Vortioxetine can be decreased when combined with Cyclophosphamide. |
Abiraterone | Abiraterone The metabolism of Vortioxetine can be decreased when combined with Abiraterone. |
Rivaroxaban | Rivaroxaban Rivaroxaban may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Ticagrelor | Ticagrelor The metabolism of Vortioxetine can be decreased when combined with Ticagrelor. |
Ruxolitinib | Ruxolitinib Ruxolitinib may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Clobazam | Clobazam The metabolism of Vortioxetine can be decreased when combined with Clobazam. |
Vemurafenib | Vemurafenib The metabolism of Vortioxetine can be decreased when combined with Vemurafenib. |
Vismodegib | Vismodegib The metabolism of Vortioxetine can be decreased when combined with Vismodegib. |
Ivacaftor | Ivacaftor The metabolism of Vortioxetine can be decreased when combined with Ivacaftor. |
Deferiprone | Deferiprone Deferiprone may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Axitinib | Axitinib The metabolism of Vortioxetine can be decreased when combined with Axitinib. |
Crizotinib | Crizotinib The metabolism of Vortioxetine can be decreased when combined with Crizotinib. |
Cabergoline | Cabergoline Cabergoline may increase the vasoconstricting activities of Vortioxetine. |
Naloxone Injection | Naloxone Injection Naloxone may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Ambrisentan | Ambrisentan The metabolism of Vortioxetine can be decreased when combined with Ambrisentan. |
Fondaparinux Injection | Fondaparinux Injection Fondaparinux may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Ezogabine | Ezogabine The risk or severity of adverse effects can be increased when Tiagabine is combined with Vortioxetine. |
Enzalutamide | Enzalutamide The metabolism of Vortioxetine can be increased when combined with Enzalutamide. |
Mirabegron | Mirabegron The metabolism of Vortioxetine can be decreased when combined with Mirabegron. |
Regorafenib | Regorafenib The metabolism of Vortioxetine can be decreased when combined with Regorafenib. |
Bosutinib | Bosutinib The metabolism of Vortioxetine can be decreased when combined with Bosutinib. |
Teriflunomide | Teriflunomide The metabolism of Vortioxetine can be decreased when combined with Teriflunomide. |
Cabozantinib (thyroid cancer) | Cabozantinib (thyroid cancer) The metabolism of Vortioxetine can be decreased when combined with Cabozantinib. |
Teduglutide Injection | Teduglutide Injection Teduglutide may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Alogliptin | Alogliptin Alogliptin may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Ponatinib | Ponatinib The metabolism of Vortioxetine can be decreased when combined with Ponatinib. |
Pomalidomide | Pomalidomide The risk or severity of adverse effects can be increased when Pomalidomide is combined with Vortioxetine. |
Ado-trastuzumab Emtansine Injection | Ado-trastuzumab Emtansine Injection The metabolism of Vortioxetine can be decreased when combined with Trastuzumab emtansine. |
Apixaban | Apixaban The metabolism of Vortioxetine can be decreased when combined with Apixaban. |
Canagliflozin | Canagliflozin Canagliflozin may increase the excretion rate of Vortioxetine which could result in a lower serum level and potentially a reduction in efficacy. |
Methazolamide | Methazolamide Methazolamide may increase the excretion rate of Vortioxetine which could result in a lower serum level and potentially a reduction in efficacy. |
Dabrafenib | Dabrafenib The serum concentration of Vortioxetine can be decreased when it is combined with Dabrafenib. |
Ospemifene | Ospemifene The metabolism of Vortioxetine can be decreased when combined with Ospemifene. |
Trametinib | Trametinib The metabolism of Vortioxetine can be decreased when combined with Trametinib. |
Levomilnacipran | Levomilnacipran The risk or severity of adverse effects can be increased when Levomilnacipran is combined with Vortioxetine. |
Ertapenem Injection | Ertapenem Injection Ertapenem may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Perampanel | Perampanel Perampanel may increase the central nervous system depressant (CNS depressant) activities of Vortioxetine. |
Ibrutinib | Ibrutinib The metabolism of Vortioxetine can be decreased when combined with Ibrutinib. |
Ketorolac Injection | Ketorolac Injection Ketorolac may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Sofosbuvir | Sofosbuvir Sofosbuvir may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Dapagliflozin | Dapagliflozin The metabolism of Vortioxetine can be decreased when combined with Dapagliflozin. |
Apremilast | Apremilast The metabolism of Vortioxetine can be increased when combined with Apremilast. |
Droxidopa | Droxidopa Vortioxetine may increase the hypertensive activities of Droxidopa. |
Ceritinib | Ceritinib The metabolism of Vortioxetine can be decreased when combined with Ceritinib. |
Siltuximab Injection | Siltuximab Injection The metabolism of Vortioxetine can be increased when combined with Siltuximab. |
Eslicarbazepine | Eslicarbazepine The risk or severity of adverse effects can be increased when Vortioxetine is combined with Eslicarbazepine. |
Testosterone Injection | Testosterone Injection The metabolism of Vortioxetine can be decreased when combined with Testosterone. |
Oritavancin Injection | Oritavancin Injection The metabolism of Vortioxetine can be decreased when combined with Oritavancin. |
Hydrocodone | Hydrocodone Hydrocodone may increase the central nervous system depressant (CNS depressant) activities of Vortioxetine. |
Suvorexant | Suvorexant Vortioxetine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant. |
Edoxaban | Edoxaban Vortioxetine may decrease the excretion rate of Edoxaban which could result in a higher serum level. |
Olaparib | Olaparib The metabolism of Olaparib can be decreased when combined with Vortioxetine. |
Methamphetamine | Methamphetamine The risk or severity of adverse effects can be increased when Metamfetamine is combined with Vortioxetine. |
Tasimelteon | Tasimelteon The risk or severity of adverse effects can be increased when Vortioxetine is combined with Tasimelteon. |
Riociguat | Riociguat The metabolism of Vortioxetine can be decreased when combined with Riociguat. |
Secukinumab Injection | Secukinumab Injection The metabolism of Vortioxetine can be increased when combined with Secukinumab. |
Risperidone Injection | Risperidone Injection The risk or severity of adverse effects can be increased when Risperidone is combined with Vortioxetine. |
Lenvatinib | Lenvatinib The metabolism of Vortioxetine can be decreased when combined with Lenvatinib. |
Naloxegol | Naloxegol The metabolism of Vortioxetine can be decreased when combined with Naloxegol. |
Panobinostat | Panobinostat The metabolism of Vortioxetine can be decreased when combined with Panobinostat. |
Haloperidol Injection | Haloperidol Injection The risk or severity of CNS depression can be increased when Haloperidol is combined with Vortioxetine. |
Amiloride | Amiloride Amiloride may increase the excretion rate of Vortioxetine which could result in a lower serum level and potentially a reduction in efficacy. |
Macitentan | Macitentan Macitentan may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Flibanserin | Flibanserin The risk or severity of adverse effects can be increased when Flibanserin is combined with Vortioxetine. |
Rolapitant | Rolapitant The metabolism of Vortioxetine can be decreased when combined with Rolapitant. |
Daclatasvir | Daclatasvir The metabolism of Daclatasvir can be decreased when combined with Vortioxetine. |
Brexpiprazole | Brexpiprazole The risk or severity of adverse effects can be increased when Vortioxetine is combined with Brexpiprazole. |
Ziprasidone Injection | Ziprasidone Injection The risk or severity of adverse effects can be increased when Ziprasidone is combined with Vortioxetine. |
Cariprazine | Cariprazine The risk or severity of adverse effects can be increased when Cariprazine is combined with Vortioxetine. |
Penicillin G Procaine Injection | Penicillin G Procaine Injection Vortioxetine may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level. |
Eluxadoline | Eluxadoline The risk or severity of serotonin syndrome can be increased when Vortioxetine is combined with Eluxadoline. |
Trabectedin Injection | Trabectedin Injection The metabolism of Vortioxetine can be decreased when combined with Trabectedin. |
Ixazomib | Ixazomib Vortioxetine may decrease the excretion rate of Ixazomib which could result in a higher serum level. |
Rifapentine | Rifapentine The metabolism of Vortioxetine can be increased when combined with Rifapentine. |
Lesinurad | Lesinurad Vortioxetine may decrease the excretion rate of Lesinurad which could result in a higher serum level. |
Amphotericin B Liposomal Injection | Amphotericin B Liposomal Injection Amphotericin B may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Dexamethasone Injection | Dexamethasone Injection The metabolism of Vortioxetine can be increased when combined with Dexamethasone. |
Brivaracetam Injection | Brivaracetam Injection The metabolism of Vortioxetine can be decreased when combined with Brivaracetam. |
Cobicistat | Cobicistat The metabolism of Vortioxetine can be decreased when combined with Cobicistat. |
Midodrine | Midodrine The risk or severity of hypertension can be increased when Midodrine is combined with Vortioxetine. |
Selexipag | Selexipag The metabolism of Selexipag can be decreased when combined with Vortioxetine. |
Pimavanserin | Pimavanserin The risk or severity of adverse effects can be increased when Pimavanserin is combined with Vortioxetine. |
Diphenhydramine Injection | Diphenhydramine Injection The risk or severity of adverse effects can be increased when Diphenhydramine is combined with Vortioxetine. |
Furosemide Injection | Furosemide Injection Furosemide may increase the excretion rate of Vortioxetine which could result in a lower serum level and potentially a reduction in efficacy. |
Rucaparib | Rucaparib The metabolism of Vortioxetine can be decreased when combined with Rucaparib. |
Lixisenatide Injection | Lixisenatide Injection Vortioxetine may decrease the excretion rate of Lixisenatide which could result in a higher serum level. |
Brigatinib | Brigatinib The metabolism of Brigatinib can be decreased when combined with Vortioxetine. |
Doxepin (Insomnia) | Doxepin (Insomnia) Doxepin may increase the central nervous system depressant (CNS depressant) activities of Vortioxetine. |
Deutetrabenazine | Deutetrabenazine Vortioxetine may decrease the excretion rate of Deutetrabenazine which could result in a higher serum level. |
Valbenazine | Valbenazine Vortioxetine may decrease the excretion rate of Valbenazine which could result in a higher serum level. |
Deflazacort | Deflazacort The metabolism of Vortioxetine can be increased when combined with Deflazacort. |
Safinamide | Safinamide The metabolism of Vortioxetine can be decreased when combined with Safinamide. |
Naldemedine | Naldemedine Vortioxetine may decrease the excretion rate of Naldemedine which could result in a higher serum level. |
Midostaurin | Midostaurin The metabolism of Vortioxetine can be increased when combined with Midostaurin. |
Enasidenib | Enasidenib The metabolism of Vortioxetine can be decreased when combined with Enasidenib. |
Benznidazole | Benznidazole Vortioxetine may decrease the excretion rate of Benznidazole which could result in a higher serum level. |
Copanlisib Injection | Copanlisib Injection The metabolism of Copanlisib can be decreased when combined with Vortioxetine. |
Delafloxacin | Delafloxacin Vortioxetine may decrease the excretion rate of Delafloxacin which could result in a higher serum level. |
Acalabrutinib | Acalabrutinib The metabolism of Vortioxetine can be decreased when combined with Acalabrutinib. |
Letermovir | Letermovir The metabolism of Vortioxetine can be decreased when combined with Letermovir. |
Tetrabenazine | Tetrabenazine The metabolism of Vortioxetine can be decreased when combined with Tetrabenazine. |
Ertugliflozin | Ertugliflozin Ertugliflozin may increase the excretion rate of Vortioxetine which could result in a lower serum level and potentially a reduction in efficacy. |
Buprenorphine Injection | Buprenorphine Injection Vortioxetine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine. |
Apalutamide | Apalutamide The metabolism of Vortioxetine can be increased when combined with Apalutamide. |
Avatrombopag | Avatrombopag The metabolism of Vortioxetine can be increased when combined with Avatrombopag. |
Baricitinib | Baricitinib Vortioxetine may decrease the excretion rate of Baricitinib which could result in a higher serum level. |
Lofexidine | Lofexidine The therapeutic efficacy of Vortioxetine can be increased when used in combination with Lofexidine. |
Plazomicin Injection | Plazomicin Injection Vortioxetine may decrease the excretion rate of Plazomicin which could result in a higher serum level. |
Eliglustat | Eliglustat The metabolism of Vortioxetine can be decreased when combined with Eliglustat. |
Encorafenib | Encorafenib The metabolism of Encorafenib can be decreased when combined with Vortioxetine. |
Elagolix | Elagolix The metabolism of Elagolix can be decreased when combined with Vortioxetine. |
Doravirine | Doravirine The metabolism of Doravirine can be decreased when combined with Vortioxetine. |
Tafenoquine | Tafenoquine The metabolism of Vortioxetine can be decreased when combined with Tafenoquine. |
Cannabidiol | Cannabidiol The risk or severity of adverse effects can be increased when Cannabidiol is combined with Vortioxetine. |
Dacomitinib | Dacomitinib The metabolism of Vortioxetine can be decreased when combined with Dacomitinib. |
Stiripentol | Stiripentol The metabolism of Vortioxetine can be decreased when combined with Stiripentol. |
Gilteritinib | Gilteritinib The therapeutic efficacy of Vortioxetine can be decreased when used in combination with Gilteritinib. |
Glasdegib | Glasdegib The metabolism of Glasdegib can be decreased when combined with Vortioxetine. |
Lorlatinib | Lorlatinib The metabolism of Lorlatinib can be decreased when combined with Vortioxetine. |
Paclitaxel (with albumin) Injection | Paclitaxel (with albumin) Injection The metabolism of Paclitaxel can be decreased when combined with Vortioxetine. |
Rifamycin | Rifamycin The metabolism of Vortioxetine can be increased when combined with Rifamycin. |
Prucalopride | Prucalopride Prucalopride may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Emapalumab-lzsg Injection | Emapalumab-lzsg Injection The metabolism of Vortioxetine can be increased when combined with Emapalumab. |
Siponimod | Siponimod The metabolism of Siponimod can be decreased when combined with Vortioxetine. |
Acyclovir Ophthalmic | Acyclovir Ophthalmic Acyclovir may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Erdafitinib | Erdafitinib The metabolism of Erdafitinib can be decreased when combined with Vortioxetine. |
Esomeprazole Injection | Esomeprazole Injection The metabolism of Vortioxetine can be decreased when combined with Esomeprazole. |
Alpelisib | Alpelisib The serum concentration of Vortioxetine can be decreased when it is combined with Alpelisib. |
Brexanolone Injection | Brexanolone Injection The risk or severity of adverse effects can be increased when Vortioxetine is combined with Brexanolone. |
Solriamfetol | Solriamfetol The risk or severity of hypertension can be increased when Solriamfetol is combined with Vortioxetine. |
Triclabendazole | Triclabendazole The metabolism of Vortioxetine can be decreased when combined with Triclabendazole. |
Istradefylline | Istradefylline The metabolism of Istradefylline can be decreased when combined with Vortioxetine. |
Pitolisant | Pitolisant The serum concentration of Vortioxetine can be decreased when it is combined with Pitolisant. |
Fedratinib | Fedratinib The metabolism of Fedratinib can be decreased when combined with Vortioxetine. |
Phenytoin Injection | Phenytoin Injection The metabolism of Vortioxetine can be increased when combined with Phenytoin. |
Fosphenytoin Injection | Fosphenytoin Injection The metabolism of Vortioxetine can be increased when combined with Fosphenytoin. |
Zanubrutinib | Zanubrutinib The metabolism of Zanubrutinib can be decreased when combined with Vortioxetine. |
Voxelotor | Voxelotor The metabolism of Voxelotor can be decreased when combined with Vortioxetine. |
Avapritinib | Avapritinib The metabolism of Avapritinib can be decreased when combined with Vortioxetine. |
Lumateperone | Lumateperone The risk or severity of adverse effects can be increased when Vortioxetine is combined with Lumateperone. |
Lasmiditan | Lasmiditan The risk or severity of serotonin syndrome can be increased when Vortioxetine is combined with Lasmiditan. |
Cenobamate | Cenobamate The serum concentration of Vortioxetine can be decreased when it is combined with Cenobamate. |
Ozanimod | Ozanimod The metabolism of Ozanimod can be decreased when combined with Vortioxetine. |
Selumetinib | Selumetinib The metabolism of Selumetinib can be decreased when combined with Vortioxetine. |
Tucatinib | Tucatinib The metabolism of Tucatinib can be decreased when combined with Vortioxetine. |
Selpercatinib | Selpercatinib The serum concentration of Selpercatinib can be increased when it is combined with Vortioxetine. |
Lemborexant | Lemborexant The serum concentration of Vortioxetine can be decreased when it is combined with Lemborexant. |
Fenfluramine | Fenfluramine The risk or severity of serotonin syndrome can be increased when Fenfluramine is combined with Vortioxetine. |
Pralsetinib | Pralsetinib The metabolism of Vortioxetine can be decreased when combined with Pralsetinib. |
Opicapone | Opicapone The metabolism of Vortioxetine can be decreased when combined with Opicapone. |
Satralizumab-mwge Injection | Satralizumab-mwge Injection The serum concentration of Vortioxetine can be decreased when it is combined with Satralizumab. |
Naxitamab-gqgk Injection | Naxitamab-gqgk Injection The risk or severity of hypertension can be increased when Vortioxetine is combined with Naxitamab. |
Progestin-Only (drospirenone) Oral Contraceptives | Progestin-Only (drospirenone) Oral Contraceptives Drospirenone may increase the excretion rate of Vortioxetine which could result in a lower serum level and potentially a reduction in efficacy. |
Viloxazine | Viloxazine The risk or severity of adverse effects can be increased when Vortioxetine is combined with Viloxazine. |
Tobramycin Injection | Tobramycin Injection Tobramycin may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Theophylline | Theophylline The metabolism of Vortioxetine can be decreased when combined with Theophylline. |
Fenoprofen | Fenoprofen Fenoprofen may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Indomethacin | Indomethacin Indomethacin may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Mefenamic Acid | Mefenamic Acid The metabolism of Vortioxetine can be decreased when combined with Mefenamic acid. |
Naproxen | Naproxen Naproxen may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Tolmetin | Tolmetin Tolmetin may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Sulindac | Sulindac Sulindac may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Trazodone | Trazodone The risk or severity of serotonin syndrome can be increased when Trazodone is combined with Vortioxetine. |
Isotretinoin | Isotretinoin Isotretinoin may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Sucralfate | Sucralfate Sucralfate may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Hydroxyurea | Hydroxyurea The metabolism of Vortioxetine can be decreased when combined with Hydroxyurea. |
Floxuridine | Floxuridine The metabolism of Vortioxetine can be decreased when combined with Floxuridine. |
Phenobarbital | Phenobarbital The metabolism of Vortioxetine can be increased when combined with Phenobarbital. |
Metaxalone | Metaxalone The risk or severity of adverse effects can be increased when Metaxalone is combined with Vortioxetine. |
Methotrexate Injection | Methotrexate Injection Methotrexate may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Levorphanol | Levorphanol The risk or severity of adverse effects can be increased when Levorphanol is combined with Vortioxetine. |
Primidone | Primidone The metabolism of Vortioxetine can be increased when combined with Primidone. |
Methsuximide | Methsuximide The metabolism of Vortioxetine can be decreased when combined with Methsuximide. |
Diethylpropion | Diethylpropion The risk or severity of adverse effects can be increased when Diethylpropion is combined with Vortioxetine. |
Chlorpromazine | Chlorpromazine The metabolism of Vortioxetine can be decreased when combined with Chlorpromazine. |
Diazepam | Diazepam The risk or severity of adverse effects can be increased when Diazepam is combined with Vortioxetine. |
Oxazepam | Oxazepam The risk or severity of adverse effects can be increased when Oxazepam is combined with Vortioxetine. |
Flurazepam | Flurazepam The risk or severity of adverse effects can be increased when Flurazepam is combined with Vortioxetine. |
Clorazepate | Clorazepate The risk or severity of adverse effects can be increased when Clorazepic acid is combined with Vortioxetine. |
Lorazepam | Lorazepam The risk or severity of adverse effects can be increased when Lorazepam is combined with Vortioxetine. |
Phenoxybenzamine | Phenoxybenzamine The risk or severity of hypertension can be increased when Phenoxybenzamine is combined with Vortioxetine. |
Carmustine | Carmustine Carmustine may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Amantadine | Amantadine The risk or severity of serotonin syndrome can be increased when Amantadine is combined with Vortioxetine. |
Codeine | Codeine The risk or severity of adverse effects can be increased when Codeine is combined with Vortioxetine. |
Meprobamate | Meprobamate The risk or severity of adverse effects can be increased when Meprobamate is combined with Vortioxetine. |
Chlordiazepoxide | Chlordiazepoxide The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Vortioxetine. |
Bromocriptine | Bromocriptine Bromocriptine may increase the vasoconstricting activities of Vortioxetine. |
Metaproterenol | Metaproterenol The risk or severity of hypertension can be increased when Orciprenaline is combined with Vortioxetine. |
Tranylcypromine | Tranylcypromine The metabolism of Vortioxetine can be decreased when combined with Tranylcypromine. |
Phenelzine | Phenelzine The metabolism of Vortioxetine can be decreased when combined with Phenelzine. |
Procarbazine | Procarbazine The metabolism of Vortioxetine can be decreased when combined with Procarbazine. |
Ergoloid Mesylates | Ergoloid Mesylates Ergoloid mesylate may increase the vasoconstricting activities of Vortioxetine. |
Tetracycline | Tetracycline Tetracycline may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Minocycline | Minocycline Minocycline may increase the central nervous system depressant (CNS depressant) activities of Vortioxetine. |
Prochlorperazine | Prochlorperazine The risk or severity of adverse effects can be increased when Prochlorperazine is combined with Vortioxetine. |
Thioridazine | Thioridazine The metabolism of Vortioxetine can be decreased when combined with Thioridazine. |
Trifluoperazine | Trifluoperazine The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Vortioxetine. |
Bleomycin | Bleomycin Bleomycin may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Dapsone | Dapsone The metabolism of Vortioxetine can be decreased when combined with Dapsone. |
Sulfadiazine | Sulfadiazine The metabolism of Vortioxetine can be decreased when combined with Sulfadiazine. |
Oxycodone | Oxycodone The risk or severity of adverse effects can be increased when Oxycodone is combined with Vortioxetine. |
Methadone | Methadone The risk or severity of adverse effects can be increased when Methadone is combined with Vortioxetine. |
Oxybutynin | Oxybutynin The metabolism of Vortioxetine can be decreased when combined with Oxybutynin. |
Benztropine | Benztropine Benzatropine may increase the central nervous system depressant (CNS depressant) activities of Vortioxetine. |
Maprotiline | Maprotiline The risk or severity of adverse effects can be increased when Maprotiline is combined with Vortioxetine. |
Ibuprofen | Ibuprofen Ibuprofen may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Trihexyphenidyl | Trihexyphenidyl Vortioxetine may increase the central nervous system depressant (CNS depressant) activities of Trihexyphenidyl. |
Orphenadrine | Orphenadrine Vortioxetine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine. |
Perphenazine | Perphenazine The risk or severity of adverse effects can be increased when Perphenazine is combined with Vortioxetine. |
Azathioprine | Azathioprine Azathioprine may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Fluphenazine | Fluphenazine The risk or severity of adverse effects can be increased when Fluphenazine is combined with Vortioxetine. |
Phentermine | Phentermine The risk or severity of serotonin syndrome can be increased when Phentermine is combined with Vortioxetine. |
Methylphenidate | Methylphenidate Methylphenidate may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Amoxapine | Amoxapine The metabolism of Amoxapine can be decreased when combined with Vortioxetine. |
Sulfasalazine | Sulfasalazine Sulfasalazine may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Hydrocortisone | Hydrocortisone The metabolism of Vortioxetine can be increased when combined with Hydrocortisone. |
Doxorubicin | Doxorubicin The metabolism of Vortioxetine can be decreased when combined with Doxorubicin. |
Phenazopyridine | Phenazopyridine Phenazopyridine may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Carbamazepine | Carbamazepine The metabolism of Vortioxetine can be increased when combined with Carbamazepine. |
Molindone | Molindone The risk or severity of adverse effects can be increased when Molindone is combined with Vortioxetine. |
Methyldopa | Methyldopa Methyldopa may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Clonidine | Clonidine The risk or severity of sedation can be increased when Clonidine is combined with Vortioxetine. |
Prazosin | Prazosin Vortioxetine may decrease the antihypertensive activities of Prazosin. |
Hydralazine | Hydralazine Hydralazine may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Cimetidine | Cimetidine The metabolism of Vortioxetine can be decreased when combined with Cimetidine. |
Gentamicin Injection | Gentamicin Injection Gentamicin may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Warfarin | Warfarin The metabolism of Vortioxetine can be decreased when combined with Warfarin. |
Clonazepam | Clonazepam The risk or severity of adverse effects can be increased when Clonazepam is combined with Vortioxetine. |
Loperamide | Loperamide The metabolism of Vortioxetine can be decreased when combined with Loperamide. |
Promethazine | Promethazine The metabolism of Vortioxetine can be decreased when combined with Promethazine. |
Meclofenamate | Meclofenamate Meclofenamic acid may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Daunorubicin | Daunorubicin The metabolism of Vortioxetine can be increased when combined with Daunorubicin. |
Nitrofurantoin | Nitrofurantoin Nitrofurantoin may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Griseofulvin | Griseofulvin The metabolism of Vortioxetine can be increased when combined with Griseofulvin. |
Digoxin | Digoxin Vortioxetine may decrease the excretion rate of Digoxin which could result in a higher serum level. |
Loxapine | Loxapine The risk or severity of adverse effects can be increased when Loxapine is combined with Vortioxetine. |
Chloroquine | Chloroquine The metabolism of Vortioxetine can be decreased when combined with Chloroquine. |
Quinine | Quinine The metabolism of Vortioxetine can be decreased when combined with Quinine. |
Ethosuximide | Ethosuximide The risk or severity of adverse effects can be increased when Ethosuximide is combined with Vortioxetine. |
Triamterene | Triamterene Triamterene may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Sulfinpyrazone | Sulfinpyrazone The metabolism of Vortioxetine can be decreased when combined with Sulfinpyrazone. |
Chlorothiazide | Chlorothiazide Chlorothiazide may increase the excretion rate of Vortioxetine which could result in a lower serum level and potentially a reduction in efficacy. |
Chlorthalidone | Chlorthalidone Chlorthalidone may increase the excretion rate of Vortioxetine which could result in a lower serum level and potentially a reduction in efficacy. |
Metolazone | Metolazone Metolazone may increase the excretion rate of Vortioxetine which could result in a lower serum level and potentially a reduction in efficacy. |
Isosorbide | Isosorbide Isosorbide may increase the excretion rate of Vortioxetine which could result in a lower serum level and potentially a reduction in efficacy. |
Clindamycin Injection | Clindamycin Injection The metabolism of Vortioxetine can be decreased when combined with Clindamycin. |
Secobarbital | Secobarbital The metabolism of Vortioxetine can be increased when combined with Secobarbital. |
Desipramine | Desipramine The metabolism of Vortioxetine can be decreased when combined with Desipramine. |
Amitriptyline | Amitriptyline The metabolism of Vortioxetine can be decreased when combined with Amitriptyline. |
Imipramine | Imipramine The metabolism of Vortioxetine can be decreased when combined with Imipramine. |
Probenecid | Probenecid The metabolism of Vortioxetine can be decreased when combined with Probenecid. |
Quinidine | Quinidine The metabolism of Vortioxetine can be decreased when combined with Quinidine. |
Procainamide | Procainamide The metabolism of Procainamide can be decreased when combined with Vortioxetine. |
Isoniazid | Isoniazid The metabolism of Vortioxetine can be decreased when combined with Isoniazid. |
Pyrazinamide | Pyrazinamide Pyrazinamide may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Rifampin | Rifampin The metabolism of Vortioxetine can be increased when combined with Rifampicin. |
Disopyramide | Disopyramide Disopyramide may increase the central nervous system depressant (CNS depressant) activities of Vortioxetine. |
Valproic Acid | Valproic Acid The risk or severity of adverse effects can be increased when Valproic acid is combined with Vortioxetine. |
Tamoxifen | Tamoxifen The metabolism of Vortioxetine can be decreased when combined with Tamoxifen. |
Butabarbital | Butabarbital The risk or severity of adverse effects can be increased when Butabarbital is combined with Vortioxetine. |
Levothyroxine | Levothyroxine The metabolism of Vortioxetine can be decreased when combined with Levothyroxine. |
Liothyronine | Liothyronine Liothyronine may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Methimazole | Methimazole The metabolism of Vortioxetine can be decreased when combined with Methimazole. |
Chlorpropamide | Chlorpropamide Chlorpropamide may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Tolbutamide | Tolbutamide The metabolism of Vortioxetine can be decreased when combined with Tolbutamide. |
Tolazamide | Tolazamide Tolazamide may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Dextromethorphan | Dextromethorphan The risk or severity of adverse effects can be increased when Dextromethorphan is combined with Vortioxetine. |
Cyclobenzaprine | Cyclobenzaprine The risk or severity of CNS depression can be increased when Vortioxetine is combined with Cyclobenzaprine. |
Niacin | Niacin The metabolism of Vortioxetine can be decreased when combined with Niacin. |
Baclofen | Baclofen The risk or severity of adverse effects can be increased when Baclofen is combined with Vortioxetine. |
Doxylamine | Doxylamine Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Vortioxetine. |
Cyproheptadine | Cyproheptadine The risk or severity of adverse effects can be increased when Cyproheptadine is combined with Vortioxetine. |
Clemastine | Clemastine The metabolism of Vortioxetine can be decreased when combined with Clemastine. |
Chlorpheniramine | Chlorpheniramine The risk or severity of adverse effects can be increased when Chlorpheniramine is combined with Vortioxetine. |
Brompheniramine | Brompheniramine The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with Vortioxetine. |
Meclizine | Meclizine The risk or severity of adverse effects can be increased when Meclizine is combined with Vortioxetine. |
Ethambutol | Ethambutol Ethambutol may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Methyclothiazide | Methyclothiazide Methyclothiazide may increase the excretion rate of Vortioxetine which could result in a lower serum level and potentially a reduction in efficacy. |
Hydrochlorothiazide | Hydrochlorothiazide Hydrochlorothiazide may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Dantrolene | Dantrolene The risk or severity of adverse effects can be increased when Dantrolene is combined with Vortioxetine. |
Chlorzoxazone | Chlorzoxazone The risk or severity of adverse effects can be increased when Chlorzoxazone is combined with Vortioxetine. |
Carisoprodol | Carisoprodol The risk or severity of adverse effects can be increased when Carisoprodol is combined with Vortioxetine. |
Methocarbamol | Methocarbamol The risk or severity of adverse effects can be increased when Methocarbamol is combined with Vortioxetine. |
Pyridoxine | Pyridoxine Pyridoxine may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Folic Acid | Folic Acid Folic acid may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Disulfiram | Disulfiram The metabolism of Vortioxetine can be decreased when combined with Disulfiram. |
Propranolol (Cardiovascular) | Propranolol (Cardiovascular) The metabolism of Vortioxetine can be decreased when combined with Propranolol. |
Minoxidil | Minoxidil Vortioxetine may decrease the antihypertensive activities of Minoxidil. |
Pseudoephedrine | Pseudoephedrine The risk or severity of serotonin syndrome can be increased when Pseudoephedrine is combined with Vortioxetine. |
Nortriptyline | Nortriptyline The metabolism of Nortriptyline can be decreased when combined with Vortioxetine. |
Spironolactone | Spironolactone The metabolism of Vortioxetine can be decreased when combined with Spironolactone. |
Amphotericin B Injection | Amphotericin B Injection Amphotericin B may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Phytonadione | Phytonadione Phylloquinone may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Amikacin Injection | Amikacin Injection Amikacin may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Nadolol | Nadolol Nadolol may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Butorphanol Injection | Butorphanol Injection The risk or severity of adverse effects can be increased when Butorphanol is combined with Vortioxetine. |
Nalbuphine Injection | Nalbuphine Injection The risk or severity of adverse effects can be increased when Nalbuphine is combined with Vortioxetine. |
Allopurinol | Allopurinol Allopurinol may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Trimethobenzamide | Trimethobenzamide The risk or severity of adverse effects can be increased when Trimethobenzamide is combined with Vortioxetine. |
Flavoxate | Flavoxate Flavoxate may increase the central nervous system depressant (CNS depressant) activities of Vortioxetine. |
Fluorouracil Injection | Fluorouracil Injection The metabolism of Vortioxetine can be decreased when combined with Fluorouracil. |
Colchicine | Colchicine The metabolism of Vortioxetine can be decreased when combined with Colchicine. |
Cefaclor | Cefaclor Cefaclor may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Cefadroxil | Cefadroxil Cefadroxil may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Cefazolin Injection | Cefazolin Injection Cefazolin may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Cephalexin | Cephalexin Cephalexin may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Cefoxitin Injection | Cefoxitin Injection Cefoxitin may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Dacarbazine | Dacarbazine Dacarbazine may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Acetazolamide | Acetazolamide The risk or severity of adverse effects can be increased when Acetazolamide is combined with Vortioxetine. |
Cefotaxime Injection | Cefotaxime Injection Cefotaxime may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Calcitonin Salmon Injection | Calcitonin Salmon Injection Salmon calcitonin may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Ketoconazole | Ketoconazole The metabolism of Vortioxetine can be decreased when combined with Ketoconazole. |
Pyrantel | Pyrantel The risk or severity of adverse effects can be increased when Vortioxetine is combined with Pyrantel. |
Thiotepa Injection | Thiotepa Injection The metabolism of Vortioxetine can be decreased when combined with Thiotepa. |
Vincristine Injection | Vincristine Injection The metabolism of Vortioxetine can be decreased when combined with Vincristine. |
Captopril | Captopril Vortioxetine may decrease the antihypertensive activities of Captopril. |
Isoxsuprine | Isoxsuprine The risk or severity of hypertension can be increased when Isoxsuprine is combined with Vortioxetine. |
Vinblastine | Vinblastine The metabolism of Vortioxetine can be decreased when combined with Vinblastine. |
Ethacrynic Acid | Ethacrynic Acid Etacrynic acid may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Colistimethate Injection | Colistimethate Injection Colistimethate may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Metoprolol | Metoprolol The metabolism of Vortioxetine can be decreased when combined with Metoprolol. |
Hydroxyzine | Hydroxyzine Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Vortioxetine. |
Thiothixene | Thiothixene The risk or severity of adverse effects can be increased when Thiothixene is combined with Vortioxetine. |
Aspirin | Aspirin Acetylsalicylic acid may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Salsalate | Salsalate Salsalate may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Alprazolam | Alprazolam The risk or severity of adverse effects can be increased when Alprazolam is combined with Vortioxetine. |
Temazepam | Temazepam The risk or severity of adverse effects can be increased when Temazepam is combined with Vortioxetine. |
Triazolam | Triazolam The risk or severity of adverse effects can be increased when Triazolam is combined with Vortioxetine. |
Dicyclomine | Dicyclomine Dicyclomine may increase the central nervous system depressant (CNS depressant) activities of Vortioxetine. |
Hyoscyamine | Hyoscyamine Vortioxetine may increase the central nervous system depressant (CNS depressant) activities of Hyoscyamine. |
Propantheline | Propantheline Propantheline may increase the central nervous system depressant (CNS depressant) activities of Vortioxetine. |
Trimethoprim | Trimethoprim The metabolism of Vortioxetine can be decreased when combined with Trimethoprim. |
Diltiazem | Diltiazem The metabolism of Vortioxetine can be decreased when combined with Diltiazem. |
Nifedipine | Nifedipine The metabolism of Vortioxetine can be decreased when combined with Nifedipine. |
Timolol | Timolol The metabolism of Vortioxetine can be decreased when combined with Timolol. |
Verapamil | Verapamil The metabolism of Vortioxetine can be decreased when combined with Verapamil. |
Atenolol | Atenolol The metabolism of Vortioxetine can be decreased when combined with Atenolol. |
Pindolol | Pindolol The risk or severity of adverse effects can be increased when Pindolol is combined with Vortioxetine. |
Cisplatin Injection | Cisplatin Injection Vortioxetine may decrease the excretion rate of Cisplatin which could result in a higher serum level. |
Diflunisal | Diflunisal Diflunisal may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Piroxicam | Piroxicam Piroxicam may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Bumetanide | Bumetanide Bumetanide may increase the excretion rate of Vortioxetine which could result in a lower serum level and potentially a reduction in efficacy. |
Etoposide | Etoposide The metabolism of Vortioxetine can be decreased when combined with Etoposide. |
Glyburide | Glyburide The metabolism of Vortioxetine can be decreased when combined with Glyburide. |
Glipizide | Glipizide Glipizide may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Indapamide | Indapamide Indapamide may increase the excretion rate of Vortioxetine which could result in a lower serum level and potentially a reduction in efficacy. |
Amoxicillin | Amoxicillin Amoxicillin may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Oxacillin Injection | Oxacillin Injection Oxacillin may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Pentoxifylline | Pentoxifylline Pentoxifylline may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Pentamidine Injection | Pentamidine Injection Pentamidine may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Ceftriaxone Injection | Ceftriaxone Injection Ceftriaxone may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Labetalol | Labetalol The metabolism of Vortioxetine can be decreased when combined with Labetalol. |
Auranofin | Auranofin Auranofin may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Leuprolide Injection | Leuprolide Injection Leuprolide may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Gemfibrozil | Gemfibrozil The metabolism of Vortioxetine can be decreased when combined with Gemfibrozil. |
Guanabenz | Guanabenz The risk or severity of hypertension can be increased when Guanabenz is combined with Vortioxetine. |
Dipivefrin Ophthalmic | Dipivefrin Ophthalmic Adefovir dipivoxil may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Ceftazidime Injection | Ceftazidime Injection Ceftazidime may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Ketoprofen | Ketoprofen Ketoprofen may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Cefotetan Injection | Cefotetan Injection Cefotetan may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Pimozide | Pimozide The metabolism of Vortioxetine can be decreased when combined with Pimozide. |
Enalapril | Enalapril Vortioxetine may decrease the antihypertensive activities of Enalapril. |
Flurbiprofen | Flurbiprofen Flurbiprofen may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Amiodarone | Amiodarone The metabolism of Vortioxetine can be decreased when combined with Amiodarone. |
Aztreonam Injection | Aztreonam Injection Aztreonam may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Buspirone | Buspirone The risk or severity of serotonin syndrome can be increased when Buspirone is combined with Vortioxetine. |
Lovastatin | Lovastatin The metabolism of Vortioxetine can be decreased when combined with Lovastatin. |
Ciprofloxacin | Ciprofloxacin The metabolism of Vortioxetine can be decreased when combined with Ciprofloxacin. |
Mesalamine | Mesalamine Mesalazine may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Diclofenac | Diclofenac Diclofenac may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Fluoxetine | Fluoxetine The serum concentration of Vortioxetine can be increased when it is combined with Fluoxetine. |
Nimodipine | Nimodipine Vortioxetine may decrease the antihypertensive activities of Nimodipine. |
Clozapine | Clozapine The metabolism of Vortioxetine can be decreased when combined with Clozapine. |
Estazolam | Estazolam The risk or severity of adverse effects can be increased when Estazolam is combined with Vortioxetine. |
Idarubicin | Idarubicin The metabolism of Vortioxetine can be decreased when combined with Idarubicin. |
Didanosine | Didanosine Didanosine may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Pentostatin Injection | Pentostatin Injection Pentostatin may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Clarithromycin | Clarithromycin The metabolism of Vortioxetine can be decreased when combined with Clarithromycin. |
Benazepril | Benazepril Vortioxetine may decrease the antihypertensive activities of Benazepril. |
Etodolac | Etodolac Etodolac may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Felodipine | Felodipine The metabolism of Vortioxetine can be decreased when combined with Felodipine. |
Fosinopril | Fosinopril Fosinopril may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Nabumetone | Nabumetone Nabumetone may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Quinapril | Quinapril Vortioxetine may decrease the antihypertensive activities of Quinapril. |
Ramipril | Ramipril Vortioxetine may decrease the antihypertensive activities of Ramipril. |
Simvastatin | Simvastatin The metabolism of Vortioxetine can be decreased when combined with Simvastatin. |
Amlodipine | Amlodipine Vortioxetine may decrease the antihypertensive activities of Amlodipine. |
Teniposide Injection | Teniposide Injection The metabolism of Vortioxetine can be decreased when combined with Teniposide. |
Itraconazole | Itraconazole The metabolism of Vortioxetine can be decreased when combined with Itraconazole. |
Lisinopril | Lisinopril Lisinopril may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Oxaprozin | Oxaprozin Oxaprozin may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Atovaquone | Atovaquone The metabolism of Vortioxetine can be decreased when combined with Atovaquone. |
Rifabutin | Rifabutin The metabolism of Vortioxetine can be increased when combined with Rifabutin. |
Sotalol | Sotalol The metabolism of Sotalol can be decreased when combined with Vortioxetine. |
Bisoprolol | Bisoprolol Bisoprolol may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Zolpidem | Zolpidem Vortioxetine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem. |
Doxazosin | Doxazosin The metabolism of Vortioxetine can be decreased when combined with Doxazosin. |
Terazosin | Terazosin Vortioxetine may decrease the antihypertensive activities of Terazosin. |
Isradipine | Isradipine Isradipine may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Omeprazole | Omeprazole The metabolism of Vortioxetine can be decreased when combined with Omeprazole. |
Cisapride | Cisapride The metabolism of Vortioxetine can be decreased when combined with Cisapride. |
Gabapentin | Gabapentin The risk or severity of adverse effects can be increased when Gabapentin is combined with Vortioxetine. |
Fluvastatin | Fluvastatin The metabolism of Vortioxetine can be decreased when combined with Fluvastatin. |
Venlafaxine | Venlafaxine The metabolism of Vortioxetine can be decreased when combined with Venlafaxine. |
Fluvoxamine | Fluvoxamine The metabolism of Vortioxetine can be decreased when combined with Fluvoxamine. |
Nefazodone | Nefazodone The risk or severity of adverse effects can be increased when Nefazodone is combined with Vortioxetine. |
Lamotrigine | Lamotrigine The risk or severity of adverse effects can be increased when Lamotrigine is combined with Vortioxetine. |
Losartan | Losartan The metabolism of Vortioxetine can be decreased when combined with Losartan. |
Valacyclovir | Valacyclovir Valaciclovir may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Tramadol | Tramadol The risk or severity of serotonin syndrome can be increased when Vortioxetine is combined with Tramadol. |
Vinorelbine Injection | Vinorelbine Injection The metabolism of Vortioxetine can be decreased when combined with Vinorelbine. |
Carboplatin Injection | Carboplatin Injection Carboplatin may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Moexipril | Moexipril Vortioxetine may decrease the antihypertensive activities of Moexipril. |
Lansoprazole | Lansoprazole The metabolism of Vortioxetine can be decreased when combined with Lansoprazole. |
Ifosfamide Injection | Ifosfamide Injection The metabolism of Vortioxetine can be decreased when combined with Ifosfamide. |
Nicardipine | Nicardipine The metabolism of Vortioxetine can be decreased when combined with Nicardipine. |
Bupropion | Bupropion The risk or severity of adverse effects can be increased when Bupropion is combined with Vortioxetine. |
Ticlopidine | Ticlopidine The metabolism of Vortioxetine can be decreased when combined with Ticlopidine. |
Saquinavir | Saquinavir The metabolism of Vortioxetine can be decreased when combined with Saquinavir. |
Metformin | Metformin Metformin may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Nisoldipine | Nisoldipine Nisoldipine may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Lamivudine | Lamivudine Lamivudine may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Riluzole | Riluzole The risk or severity of adverse effects can be increased when Riluzole is combined with Vortioxetine. |
Acarbose | Acarbose Acarbose may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Glimepiride | Glimepiride The metabolism of Vortioxetine can be decreased when combined with Glimepiride. |
Anastrozole | Anastrozole The metabolism of Vortioxetine can be decreased when combined with Anastrozole. |
Gemcitabine Injection | Gemcitabine Injection Gemcitabine may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Indinavir | Indinavir The metabolism of Vortioxetine can be decreased when combined with Indinavir. |
Ritonavir | Ritonavir The serum concentration of Vortioxetine can be increased when it is combined with Ritonavir. |
Docetaxel Injection | Docetaxel Injection The metabolism of Vortioxetine can be decreased when combined with Docetaxel. |
Cidofovir Injection | Cidofovir Injection Cidofovir may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Meropenem Injection | Meropenem Injection Meropenem may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Clomipramine | Clomipramine The metabolism of Vortioxetine can be decreased when combined with Clomipramine. |
Zafirlukast | Zafirlukast The metabolism of Vortioxetine can be decreased when combined with Zafirlukast. |
Fosfomycin | Fosfomycin Fosfomycin may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Mirtazapine | Mirtazapine Vortioxetine may increase the serotonergic activities of Mirtazapine. |
Trandolapril | Trandolapril Vortioxetine may decrease the antihypertensive activities of Trandolapril. |
Topiramate | Topiramate The risk or severity of adverse effects can be increased when Topiramate is combined with Vortioxetine. |
Zileuton | Zileuton The metabolism of Vortioxetine can be decreased when combined with Zileuton. |
Valsartan | Valsartan The metabolism of Vortioxetine can be decreased when combined with Valsartan. |
Pramipexole | Pramipexole Vortioxetine may increase the sedative activities of Pramipexole. |
Donepezil | Donepezil The risk or severity of adverse effects can be increased when Donepezil is combined with Vortioxetine. |
Nelfinavir | Nelfinavir The metabolism of Vortioxetine can be decreased when combined with Nelfinavir. |
Azithromycin | Azithromycin The metabolism of Vortioxetine can be decreased when combined with Azithromycin. |
Loratadine | Loratadine The metabolism of Vortioxetine can be decreased when combined with Loratadine. |
Carvedilol | Carvedilol Vortioxetine may decrease the antihypertensive activities of Carvedilol. |
Nilutamide | Nilutamide The metabolism of Vortioxetine can be decreased when combined with Nilutamide. |
Flutamide | Flutamide Flutamide may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Selegiline | Selegiline The metabolism of Vortioxetine can be decreased when combined with Selegiline. |
Bicalutamide | Bicalutamide The metabolism of Vortioxetine can be decreased when combined with Bicalutamide. |
Sertraline | Sertraline The metabolism of Vortioxetine can be decreased when combined with Sertraline. |
Propafenone | Propafenone The metabolism of Vortioxetine can be decreased when combined with Propafenone. |
Letrozole | Letrozole The metabolism of Vortioxetine can be decreased when combined with Letrozole. |
Raloxifene | Raloxifene The metabolism of Vortioxetine can be decreased when combined with Raloxifene. |
Irbesartan | Irbesartan The metabolism of Vortioxetine can be decreased when combined with Irbesartan. |
Tamsulosin | Tamsulosin Tamsulosin may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Ropinirole | Ropinirole Vortioxetine may increase the sedative activities of Ropinirole. |
Finasteride | Finasteride The metabolism of Vortioxetine can be decreased when combined with Finasteride. |
Quetiapine | Quetiapine The risk or severity of adverse effects can be increased when Quetiapine is combined with Vortioxetine. |
Cefepime Injection | Cefepime Injection Cefepime may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Cefprozil | Cefprozil Cefprozil may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Cefpodoxime | Cefpodoxime Cefpodoxime may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Cetirizine | Cetirizine The risk or severity of adverse effects can be increased when Cetirizine is combined with Vortioxetine. |
Paroxetine | Paroxetine The metabolism of Vortioxetine can be decreased when combined with Paroxetine. |
Tolcapone | Tolcapone The risk or severity of adverse effects can be increased when Tolcapone is combined with Vortioxetine. |
Citalopram | Citalopram The risk or severity of adverse effects can be increased when Citalopram is combined with Vortioxetine. |
Capecitabine | Capecitabine The metabolism of Vortioxetine can be decreased when combined with Capecitabine. |
Efavirenz | Efavirenz The metabolism of Vortioxetine can be increased when combined with Efavirenz. |
Abacavir | Abacavir Abacavir may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Sildenafil | Sildenafil The metabolism of Vortioxetine can be decreased when combined with Sildenafil. |
Pioglitazone | Pioglitazone The metabolism of Vortioxetine can be decreased when combined with Pioglitazone. |
Celecoxib | Celecoxib The metabolism of Vortioxetine can be decreased when combined with Celecoxib. |
Rosiglitazone | Rosiglitazone The metabolism of Vortioxetine can be decreased when combined with Rosiglitazone. |
Tolterodine | Tolterodine Tolterodine may increase the central nervous system depressant (CNS depressant) activities of Vortioxetine. |
Thalidomide | Thalidomide Vortioxetine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide. |
Oseltamivir | Oseltamivir Oseltamivir may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Balsalazide | Balsalazide Balsalazide may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Nateglinide | Nateglinide Nateglinide may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Galantamine | Galantamine The metabolism of Vortioxetine can be decreased when combined with Galantamine. |
Levetiracetam | Levetiracetam The risk or severity of adverse effects can be increased when Levetiracetam is combined with Vortioxetine. |
Rabeprazole | Rabeprazole The metabolism of Vortioxetine can be decreased when combined with Rabeprazole. |
Terbinafine | Terbinafine The metabolism of Vortioxetine can be decreased when combined with Terbinafine. |
Content provided by: AHFS® Patient Medication Information™. © Copyright, 2021. The American Society of Health-System Pharmacists